Tamiflu substrate produced from Bioengineered Bacteria

by Medindia Content Team on  January 9, 2006 at 8:13 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Tamiflu substrate produced from Bioengineered Bacteria
The worldwide scare of bird flu pandemic as increased which has lead to stockpiling of large quantities of Tamiflu, antiviral bird flu drug by many countries. U.S. has stocked more than 4 million Tamiflu drugs and many countries have started producing the generic version of the drug Tamiflu manufactured by the Swiss pharmaceuticals Roche.

Due to the gold rush for shikimic acid which is used for production of Tamiflu antiviral drugs, there has been a great shortage of Chinese star anise, which contains high quality pure Shikimic acid. Shikimic acid is obtained from the seeds of Star
anise which is grown in the high altitudes in the mountains of Guanxi, Sichuan, Yunnan and Guizhou in Southwestern Chinese province. Due to shortage of Shikimic acid, Roche the manufacturer of Tamiflu is planning to use genetically bioengineered E.coli bacterium to produce shikimic acid by fermentation method. Fermentation procedures uses cheap carbohydrate source which will be used by the bioengineered E.coli as a substrate for production of high quality Shikimic acid.

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Bird Flu Shigellosis 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive